Clinical Trials · NCT02202603
A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Entera Bio Ltd.
- Enrollment
- 42
- Start date
- Jul 2011
- Locations
- 1 site, Israel
- Primary endpoint
- Adverse events